Prescription drug · NDA
Sporanox (Itraconazole) NDC 50458-290
Itraconazole 100 mg/1 · Capsule · Oral · Janssen Pharmaceuticals, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50458-290-01 | 50458029001 | 3 BLISTER PACK in 1 CARTON (50458-290-01) / 10 CAPSULE in 1 BLISTER PACKMarketed from Sep 11, 1992 | |
| 50458-290-04 | 50458029004 | 30 CAPSULE in 1 BOTTLE (50458-290-04)Marketed from Sep 11, 1992 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Sporanox
- Generic name (nonproprietary)
- itraconazole
- Active ingredients
- Itraconazole — 100 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Janssen Pharmaceuticals, Inc.NDC labeler code 50458
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 020083
- Marketing start
- Marketing end
- Other FDA classes
- Azoles (Chemical structure)Breast Cancer Resistance Protein Inhibitors (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)P-Glycoprotein Inhibitors (Mechanism)
- Identifiers
- Product ID 50458-290_a79c080b-711a-4a15-af92-ff0c60cbfdf1SPL ID a79c080b-711a-4a15-af92-ff0c60cbfdf1SPL set ID a4d555fa-787c-40fb-bb7d-b0d4f7318fd0RxCUI 311204, 833164UNII 304NUG5GF4UPC 0350458290042
- Pharmacologic class
- Azole Antifungal
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N450458029001followed by a unit qualifier and the quantityPackage 50458-0290-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE SPORANOX ® (itraconazole) Capsules are indicated for the treatment of the following fungal infections in immunocompromised and non-immunocompromised patients: Blastomycosis, pulmonary and extrapulmonary Histoplasmosis, including chronic cavitary pulmonary disease and disseminated, non-meningeal histoplasmosis, and Aspergillosis, pulmonary and extrapulmonary, in patients who are intolerant of or who are refractory to amphotericin B therapy. Specimens for fungal cultures and other relevant laboratory studies (wet mount, histopathology, serology) should be obtained before therapy to isolate and identify causative organisms. Therapy may be instituted before the results of t…
Excerpt only. Read the full label for complete information.
About NDC 50458-290
- What is NDC 50458-290?
- 50458-290 is the product NDC for Sporanox (itraconazole), Itraconazole 100 mg/1 capsule, listed with the FDA by Janssen Pharmaceuticals, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Sporanox (Itraconazole).
- What is the active ingredient?
- Itraconazole.
- Who is the labeler?
- Janssen Pharmaceuticals, Inc., NDC labeler code 50458. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Sporanox?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Other NDCs under NDA 020083
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| itraconazole | Itraconazole 100 mg/1 | CapsuleOral | Patriot Pharmaceuticals | 10147-1700 |